Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19

被引:4
|
作者
Shakrawal, Jyoti [1 ]
Sharma, Vidhu [2 ]
Goyal, Amit [2 ]
Kumar, Deepak [3 ]
Meena, Seema [1 ]
Tiwari, Sarbesh [4 ]
Jain, Vidhi [5 ]
Elhence, Poonam [6 ]
Soni, Kapil [2 ]
Choudhury, Bikram [2 ]
Bhatnagar, Kavita [1 ]
Garg, Mahendra Kumar [3 ]
Misra, Sanjeev [7 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Ophthalmol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[2] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[3] All India Inst Med Sci AIIMS, Dept Gen Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[4] All India Inst Med Sci AIIMS, Dept Diagnost & Intervent Radiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[5] All India Inst Med Sci AIIMS, Dept Microbiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[6] All India Inst Med Sci AIIMS, Dept Pathol & Lab Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[7] All India Inst Med Sci AIIMS, Dept Surg Oncol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
关键词
COVID-19; Transcutaneous retrobulbar Amphotericin B; Rhino-orbital-cerebral-mucormycosis; MANAGEMENT;
D O I
10.1007/s10792-022-02591-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy. Methods In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage >= 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name: [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you. Results Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously. Conclusion TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [1] Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
    Jyoti Shakrawal
    Vidhu Sharma
    Amit Goyal
    Deepak Kumar
    Seema Meena
    Sarbesh Tiwari
    Vidhi Jain
    Poonam Elhence
    Kapil Soni
    Bikram Choudhury
    Kavita Bhatnagar
    Mahendra Kumar Garg
    Sanjeev Misra
    International Ophthalmology, 2023, 43 : 1919 - 1926
  • [2] Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review
    Nair, Akshay Gopinathan
    Dave, Tarjani Vivek
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (03): : 275 - 286
  • [3] Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience
    Sinha, Shivani
    Kumar, Vidya B.
    Kumar, Abhay
    Singh, Vivek
    Anand, Abhishek
    Kusumesh, Rakhi
    Mishra, Sarita
    Raj, Pragati
    Sinha, Bibhuti P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [4] Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
    Singh, Prabhakar
    Gupta, Abhishek
    Sanepalli, Sravani Reddy
    Raj, Amit
    BMJ CASE REPORTS, 2022, 15 (03)
  • [5] Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study
    Dave, Tarjani Vivek
    Gopinathan Nair, Akshay
    Hegde, Raghuraj
    Vithalani, Nidhi
    Desai, Savari
    Adulkar, Namrata
    Kamal, Saurabh
    Mittal, Raman
    Bradoo, Renuka A.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (05): : 488 - 495
  • [6] Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study
    Dallalzadeh, Liane O. O.
    Ediriwickrema, Lilangi S. S.
    Fung, Sammie E. E.
    Men, Clara J. J.
    Kossler, Andrea L. L.
    Kupcha, Anna C. C.
    Mawn, Louise A. A.
    Burkat, Cat N. N.
    van Landingham, Suzanne W. W.
    Conger, Jordan R. R.
    Simmons, Brittany
    Pham, Chau
    Akella, Sruti S. S.
    Setabutr, Pete
    Ho, Tiffany
    Couch, Steven M. M.
    Kim, Jane S. S.
    Demirci, Hakan
    Korn, Bobby S. S.
    Kikkawa, Don O. O.
    Liu, Catherine Y. Y.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (01): : 41 - 48
  • [7] Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study
    Gandhi, Aastha
    Narula, Anurag
    Chandra, Shreya
    Agarwal, Dhwanee
    Mehta, Anuj
    Nayak, Shaktiprada
    Arora, Sheetal
    Capoor, Malini R.
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (05) : 1571 - 1580
  • [8] Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study
    Aastha Gandhi
    Anurag Narula
    Shreya Chandra
    Dhwanee Agarwal
    Anuj Mehta
    Shaktiprada Nayak
    Sheetal Arora
    Malini R. Capoor
    International Ophthalmology, 2023, 43 : 1571 - 1580
  • [9] Post Covid-19 rhino-orbital-cerebral mucormycosis presenting as unilateral headache
    Dubey, A.
    Dubey, S.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
  • [10] Post Covid-19 rhino-orbital-cerebral mucormycosis presenting as unilateral headache
    Dubey, A.
    Dubey, S.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 243 - 243